BRIAN HAM: Open Payments
NPI 1053505909 · CHATTAHOOCHEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 33 payments from 10 companies in 2025. Trend: 2023 $960 · 2024 $768 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $167 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Novo Nordisk Inc | 4 | $70 |
| PFIZER INC. | 3 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Abbott Laboratories | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
Products named: VRAYLAR, AIRSUPRA, NURTEC ODT, XIFAXAN, Ozempic, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
